BMO US Aggregate Bond Index ETF (ZUAG.U) Cotización

What's another 569 million shares between friends? No biggie! Don't worry, it won't impact the value of a company with 1.2 billion outstanding shares, I promise! ;-)

Pre-existing obligations: The plaintiff, EROP, in a lawsuit was owed $825,000, plus attorney's fees and other costs.

Or either 9mm bullets.
That might be one the real gold.
I think we get to that, Gold will be $30k+an Oz

You might not want to be living in that world

I'll be trading my cans of Vienna sausages for anything I want. Shelf life of 130 years.

Use your little brain, little man. You’ll figure it out when you finally get educated.

The answer is right in front of your face. But you can’t seem to process it! LMAO

IMHO

And yet still overall a low volume day

No thanks. I'll believe TenKay's assessment.

George knows how to do it He is not wasting money Fake Negativity baseless 

Dump All svix > wait for tarriff smoke to clear then reload
played it wrong but No loss

Thanks very interesting. What I'm wondering though.

If accountants in Spain cannot file quarterlies in a timely fashion. Do you have any clear reasoning why AFFU can't send Quarterlies filing data 2 weeks earlier. Not like asking for the moon from what I can see. They're not trading i

Who said anything about a PR. Just asking if you like Mondays.

If buy backs was going on, why are the number of authorized shares never being reduced. In fact in the last year they increased substantially. Humble lies not only for himself, but for Holman also.
We recently went from 350 billion shares to the current number of 481 billion shares. Does that

Haywood Securities has initiated coverage on Borealis Mining (BOGO.v) with a BUY rating and $1.30 target price following its recent acquisition of Gold Bull Resources as the company resumes small scale gold production at its 100% owned Borealis Mine alongside advancing the recently acquired Sandman

GDVM: Thanks Gov that’s a very credible poster on X. (Jmetrish)

Looking good here. L2 is cleaned up. Ticker change will send this and make it available in multiple new markets.

Please read these latest solid updates!

GDVM: ERATE Contracts Won and more

Why are you so mad, bent out of shape over a simple question, nobody’s crying FF, again, if this is a scam, shouldn’t you be on the horn with the FDA to tell them their getting hood winked, give them a call and let us know what they tell you

$BURU - Importantly, this investment comes on the heels of NUBURU’s successful initiatives to eliminate 100% of its outstanding long-term indebtedness, enabling the Company to pursue fresh capital in support of its transformation plan, which includes the strategic investment in SYME. The adoption of

Nope...

For some reason, I’m feeling very optimistic about the good news in the 10K, and I believe we’ll receive it either today or Monday. I truly think better days are ahead. I’m tired of the daily frustration. 😊

And yet, she already has a regulatory license in the UK to run Advent on behalf of Northwest. Keep up!

Still hanging in there like a hair in a biscuit from McDonald’s…. 😉

JHD, many people are not aware of certain terms and one of them is Safe Harbor, bankruptcy remote assets that DO NOT have to be declared hence, the terms show that by the names.

WaMu ensured that many of these assets followed the strict guidelines to ensure they are Safe Harbor protec

I pretty much agree with all your positions you post on FnF, but you have lost credibility brother.

Explain what a PDK that available in 2 foundries means.  I'm not sure that you "get it".
It a big deal, the market will move it however it chooses.
That was a very relevant PR the Friday before the conference.
X. I wish you all the happiness in the world.

VOLUME 
12,500

more like fecal hands. You don't touch or play with turds. Sub 12 cents kool aide drinker.

$COEP - "By leveraging specific sites, we aim to enable GEAR-modified immune cells, NK cells in this instance, to be co-administered in combination with antibodies in a manner that largely avoids undesired ‘on target/off tumor effects’ on a plethora of combination or retargeting therapies."https://f